Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2018. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | +4.76% |
|
-.--% | +27.17% |
1st Jan change | Capi. | |
---|---|---|
+27.17% | 46.03M | |
+23.26% | 3,465B | |
+17.35% | 94.3B | |
+15.26% | 87.01B | |
+59.77% | 61.69B | |
-24.20% | 50.56B | |
+38.65% | 48.46B | |
-24.42% | 47.32B | |
+83.36% | 41.9B | |
-6.52% | 26.6B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt